Loading...
Thumbnail Image
Item

Design, synthesis, and biological activity of 1,2,3-triazolobenzodiazepine BET bromodomain inhibitors

Sharp, Phillip P.
Garnier, Jean-Marc
Hatfaludi, Tamas
Xu, Zhen
Segal, David
Jarman, Kate E.
Jousset, Hélène
Garnham, Alexandra
Feutrill, John T.
Cuzzupe, Anthony
... show 10 more
Citations
Google Scholar:
Altmetric:
Abstract
A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromodomain inhibitors with excellent activity against leukemic cells, concomitant with a reduction in c-MYC expression. These novel benzodiazepines therefore represent a promising class of therapeutic BET inhibitors.
Keywords
benzodiazepine, Bromodomain, JQ1, leukemia, triazole
Date
2017
Type
Journal article
Journal
ACS Medicinal Chemistry Letters
Book
Volume
8
Issue
12
Page Range
1298-1303
Article Number
ACU Department
Mary MacKillop Institute for Health Research
Faculty of Health Sciences